Aehr Test Systems (AEHR)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-04
$86.26+13.10%
Close 2026-09-04 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-09-04
QuarterlyIQ Insights · AEHR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 50.0 | 50.0 | 59.0 | 66.2 | 65.0 | 50.8 | 16.6 | 22.3 | 21.1 | 29.6 | 18.9 | 14.5 | 10.0 | 19.7 | 16.5 | 15.5 |
| Total Revenues | 50.0 | 50.0 | 59.0 | — | 65.0 | 50.8 | 16.6 | 22.3 | 21.1 | 29.6 | 18.9 | 14.5 | 10.0 | 19.7 | 16.5 | 15.5 |
| Cost of Revenues | 32.4 | 32.4 | 35.0 | 33.7 | 32.2 | 27.2 | 10.6 | 13.9 | 13.5 | 17.2 | 12.1 | 9.4 | 6.2 | 9.5 | 9.7 | 9.3 |
| Gross Profit | 17.7 | 17.7 | 23.9 | 32.5 | 32.7 | 23.7 | 6.0 | 8.4 | 7.6 | 12.4 | 6.8 | 5.1 | 3.8 | 10.2 | 6.8 | 6.2 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 19.2 | 19.2 | 18.3 | 13.7 | 12.2 | 10.0 | 6.6 | 7.5 | 7.7 | 7.3 | 7.1 | 7.0 | 6.5 | 6.3 | 6.9 | 6.5 |
| R&D Expenses | 12.6 | 12.6 | 10.5 | 8.7 | 7.1 | 5.8 | 3.7 | 3.4 | 4.2 | 4.2 | 4.7 | 4.3 | 4.1 | 3.4 | 3.2 | 4.2 |
| Operating Income | (14.1) | (14.1) | (5.7) | 10.1 | 13.4 | 7.8 | (4.2) | (2.8) | (5.0) | 0.9 | (4.9) | (6.2) | (6.7) | 0.5 | (3.3) | (4.5) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 0.3 | 0.4 | 0.7 | 0.6 | 0.1 | 0.0 | 0.0 | 0.0 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 |
| Asset Writedown | — | — | 0.6 | — | 0.0 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (11.7) | (11.7) | (4.3) | 12.5 | 14.6 | 9.5 | (2.2) | (2.8) | (5.2) | 0.5 | (5.6) | (6.8) | (6.6) | 0.4 | (3.4) | (3.4) |
| Income Tax Expense | (4.6) | (4.6) | (0.4) | (20.7) | 0.1 | 0.1 | (0.2) | (0.0) | 0.0 | (0.1) | 0.0 | 0.0 | 0.0 | (0.0) | 0.0 | (0.0) |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Income | (7.1) | (7.1) | (3.9) | 33.2 | 14.6 | 9.5 | (2.0) | (2.8) | (5.2) | 0.5 | (5.7) | (6.8) | (6.6) | 0.4 | (3.4) | (3.4) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (0.23) | (0.13) | 1.15 | 0.52 | 0.36 | (0.09) | (0.12) | (0.23) | 0.02 | (0.35) | (0.52) | (0.55) | 0.04 | (0.36) | (0.38) |
| Diluted EPS | — | (0.23) | (0.13) | 1.12 | 0.50 | 0.34 | (0.09) | (0.12) | (0.23) | 0.02 | (0.35) | (0.52) | (0.55) | 0.04 | (0.36) | (0.38) |
| Basic Weighted Avg Shares | — | 30.7 | 29.6 | 28.8 | 27.8 | 26.0 | 23.5 | 22.9 | 0.0 | 0.0 | 0.0 | 13.1 | 12.0 | 0.0 | 9.5 | 0.0 |
| Diluted Weighted Avg Shares | — | 30.7 | 29.6 | 29.6 | 29.2 | 27.8 | 23.5 | 22.9 | 0.0 | 0.0 | 0.0 | 13.1 | 12.0 | 0.0 | 9.5 | 0.0 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (11.4) | (3.4) | 10.7 | 13.8 | 8.2 | (3.9) | (2.4) | (4.6) | 1.3 | (4.7) | (6.0) | (6.6) | 0.6 | (3.0) | (4.0) |
| EBIT | (14.1) | (14.1) | (5.7) | 10.1 | 13.4 | 7.8 | (4.2) | (2.8) | (5.0) | 0.9 | (4.9) | (6.2) | (6.7) | 0.5 | (3.3) | (4.5) |
| Effective Tax Rate | 39.3% | — | — | — | 0.4% | 1.0% | 8.0% | 1.3% | -0.5% | -16.0% | -0.4% | -0.1% | -0.5% | -3.7% | -0.9% | 0.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.